Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma Studies.
Cancers (Basel)
; 15(2)2023 Jan 06.
Article
in En
| MEDLINE
| ID: mdl-36672345
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland